Internal Medicine, Hematology & Oncology · Massillon, OH
NPI
1780612333
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
7337 Caritas Cir NW Ste 150
Massillon, OH, 44646
Phone (330) 478-0001
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.6M
284,829 services
Medicare patients, 2024
858
Average age 75
Drug cost, 2024
$15.6M
4,946 prescriptions
Company payments, 2025
$3,453
From 48 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nagaprasad Nagajothi was code J1439 (injection, ferric carboxymaltose, 1 mg), 74,250 times for 51 patients. In total Nagaprasad Nagajothi billed 284,829 services in 147 codes, and Medicare paid $4.6M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-01.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 74,250 | 51 | $0.86 | $64K |
| J1627 Injection, granisetron, extended-release, 0.1 mg | Office | 19,400 | 43 | $4.39 | $85K |
| J0897 Injection, denosumab, 1 mg | Office | 13,380 | 84 | $20.29 | $271K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 10,200 | 11 | $44.67 | $456K |
| J0185 Injection, aprepitant, 1 mg | Office | 8,450 | 16 | $1.34 | $11K |
| J9267 Injection, paclitaxel, 1 mg | Office | 6,190 | 12 | $0.08 | $497 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,690 | 51 | $0.09 | $241 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2,645 | 21 | $6.28 | $17K |
| 85025 Blood Count | Office | 2,619 | 674 | $7.59 | $20K |
| 36415 Venipuncture Blood Collection | Office | 2,555 | 680 | $8.63 | $22K |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 1,253 | 11 | $3.53 | $4,423 |
| 99214 Office E&M - Established | Office | 1,168 | 458 | $95.64 | $112K |
| 80053 Clinical Chemistry | Office | 1,070 | 437 | $10.34 | $11K |
| J9190 Injection, fluorouracil, 500 mg | Office | 759 | 11 | $2.32 | $1,758 |
| 96372 Injection Administration | Office | 658 | 180 | $10.90 | $7,170 |
By year: 2022 $4.1M for 254,785 services; 2023 $3.8M for 263,010 services; 2024 $4.6M for 284,829 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,619 | 674 | $7.59 | $20K |
| 36415 Venipuncture Blood Collection | 2,555 | 680 | $8.63 | $22K |
| 80053 Clinical Chemistry | 1,070 | 437 | $10.34 | $11K |
| 82728 Clinical Chemistry | 471 | 246 | $13.26 | $6,245 |
| 83550 Clinical Chemistry | 461 | 242 | $8.50 | $3,921 |
| 83540 Clinical Chemistry | 461 | 242 | $6.29 | $2,900 |
| 83615 Clinical Chemistry | 371 | 156 | $5.92 | $2,196 |
| 82306 Clinical Chemistry | 188 | 109 | $29.01 | $5,454 |
| 82607 Clinical Chemistry | 168 | 119 | $14.63 | $2,458 |
| 84443 Clinical Chemistry | 106 | 49 | $16.46 | $1,745 |
Medicare prescription drug claims, 2024
In 2024, the drug Nagaprasad Nagajothi prescribed most often to Medicare patients was Anastrozole, with 549 prescriptions and refills. In total Nagaprasad Nagajothi wrote 4,946 Medicare prescriptions that cost $15.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 549 | 1,040 | 151 | $6,649 |
| Eliquis Apixaban | 248 | 292 | 53 | $166K |
| Potassium Chloride Generic | 218 | 275 | 72 | $3,021 |
| Ondansetron Hcl Generic | 164 | 164 | 95 | $16K |
| Acyclovir Generic | 141 | 167 | 34 | $1,128 |
| Alendronate Sodium Generic | 130 | 217 | 29 | $658 |
| Letrozole Generic | 126 | 180 | 31 | $1,636 |
| Lenalidomide Generic | 123 | 123 | 16 | $1.6M |
| Xarelto Rivaroxaban | 121 | 160 | 22 | $86K |
| Prednisone Generic | 111 | 116 | 31 | $685 |
| Prochlorperazine Maleate Generic | 109 | 109 | 70 | $2,540 |
| Hydroxyurea Generic | 103 | 170 | 25 | $1,654 |
| Gabapentin Generic | 102 | 132 | 21 | $1,224 |
| Loperamide Loperamide Hcl | 90 | 90 | 61 | $1,458 |
| Azacitidine Generic | 86 | 86 | Under 11 | $102K |
Brand drugs: 1,474 claims; generic drugs: 3,472 claims; opioid claims: 67.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nagaprasad Nagajothi $3,453 ($3,453 in general payments such as food, travel and fees) from 48 companies. The largest payer was Merck Sharp & Dohme LLC with $291.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 9 | $291 |
| Pfizer Inc. PFE | 16 | $234 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $226 |
| Daiichi Sankyo Inc. 4568.T | 11 | $197 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $188 |
| Janssen Biotech, Inc. JNJ | 8 | $165 |
| Eisai Inc. 4523.T | 9 | $165 |
| Astellas Pharma US Inc 4503.T | 6 | $164 |
| E.R. Squibb & Sons, L.L.C. BMY | 9 | $143 |
| SpringWorks Therapeutics, Inc. | 4 | $131 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.